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Case Study
Sleep Disorders
and Cardiac
Consequences
by Robert D. Vorona, M.D.
Eastern Virginia Medical
School
Educational Objectives:
1. Review the clear relationship
between obstructive sleep apnea
and hypertension.
2. Discuss the cardiac consequences
of sleep apnea, including coronary
heart disease, heart failure, and different dysrhythmias.
3. Understand that sleep disorders
beyond obstructive sleep apnea,
such as insufficient sleep itself, may
have an impact on the cardiovascular system.
4. Appreciate the potential benefits
of identifying and treating sleep
disorders for our health.
Background
Primary care clinicians, cardiologists, and sleep clinicians are
increasingly aware of the association between sleep disordered
breathing and a number of different

cardiovascular disorders. The
Sleep Heart Health Study and other
investigations are systematically
trying to determine type and extent
of relationships. Much of the data
linking sleep and the cardiovascular
system have focused on obstructive
sleep apnea (OSAS), which
receives relatively greater attention
here. However, we will also explore
putative associations between other
sleep disorders and the cardiovascular system and, in fact, the possible impact of reduced sleep duration itself on the cardiovascular system. Space limitations prevent an
exhaustive review of sleep disorders and the cardiovascular system.

not to drive while sleepy. Beyond
conservative recommendations, the
most common treatment options
include nasal continuous positive
airway pressure (CPAP) which
employs a blower machine, tubing
and mask assembly that acts as an
upper airway air splint; oral appliances; and surgery. Surgical
options can include soft tissue
upper airway surgery, jaw surgery,
and bariatric (weight loss) surgery.
The Heart and Sleep
Hypertension and Sleep

Obstructive sleep apnea syndrome
(OSAS) manifests with repeated
upper airway near occlusions or
temporary complete occlusions. It
is estimated that some 18 million
Americans have OSAS, which can
lead to neurocognitive, pulmonary,
and cardiovascular consequences.
OSAS can be treated conservatively
with weight loss, by minimizing
alcohol and sedative use, as well as
by unambiguously warning patients

Roughly two thirds of Americans
over the age of 60 have hypertension (Yoon et al., 2012). Sleep is
normally associated with lowered
blood pressure but this may not be
so in patients with obstructive sleep
apnea (so called non-dipping). The
majority of data suggest that OSAS
can cause elevations in blood pressure and that treatment of OSAS
lowers blood pressure. Research
from Australia in 1998 demonstrated that approximately 40% of
patients with high blood pressure
have sleep apnea, and a Wisconsin
study (Peppard et al., 2000) found a
“dose response” relationship
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between the severity of sleep apnea
at baseline and the development of
high blood pressure over the next
four years. In addition, treatment
resistant hypertension has been
associated with OSAS in between
70 and 80% of cases. Therefore, if
one has high blood pressure and,
particularly, treatment resistant
hypertension, OSAS must be considered.
The preponderance of data suggests
that treatment of OSAS does appear
to lower blood pressure. Although
the absolute amount of blood pressure reduction appears to be modest, these reductions are believed to
be meaningful. Most of the data
showing improvements in blood
pressure with treatment of OSAS
derive from CPAP studies. However, there is also evidence demonstrating that oral appliances and
surgery for OSAS may lead to
reductions in blood pressure.
Recent data suggest that sleep clinicians should look beyond just the
diagnosis of obstructive sleep apnea
when they consider the intersection
of sleep and hypertension.
RLS, PLMS, and Sleep
Restless legs syndrome (RLS)
patients describe an urge to move
(predominantly the lower extremities), at rest, most prominent at
night and relieved quickly by
movement. Some 5-10% of Americans may have RLS and it occurs
roughly twice as often in women as
in men. Most RLS subjects and
clinicians focus on the impact of
RLS on causing insomnia. However, there are now some (but not all)
studies that suggest an association
of RLS with hypertension. A 2011
study of over 65,000 middle-aged
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nurses demonstrated that RLS
increased the odds of hypertension
by 20% and that there was a dose
response relationship between the
frequency of RLS each month and
the prevalence of hypertension. We
must note that this study could not
prove a cause and effect relationship nor did it apply to males,
although earlier research in Sweden
did associate RLS and hypertension
in men.
Periodic limb movements of sleep
(PLMS) are stereotypical lower
extremity movements that occur in
approximately 85% of patients with
RLS, but such movements can be
seen in numerous other situations,
such as taking certain anti-depressants and being over 65 years of
age. It may be that these leg jerks
increase sympathetic nervous system activity, thereby leading to
hypertension during the day. It is
known that PLMS themselves have
been associated with hypertension.
For example, one study revealed
that subjects with more severe
hypertension had more PLMS than
did those with lower levels of
hypertension; other data reveal the
complementary, namely, linking
greater frequencies of PLMS with
hypertension. These and other studies can be found as references in a
comprehensive review of RLS and
PLMS and cardiovascular consequences by Walters & Rye (2009).
We may also put ourselves at risk
simply by achieving too little sleep.
Studies have revealed that insufficient sleep may be associated with
hypertension; i.e., sleep of less than
or equal to five hours a night doubled the risk of hypertension among
subjects between the ages of 32 and
59. Of interest, insufficient sleep

has also been associated with diabetes and obesity, both of which, in
turn, have been linked to heart disease and cardiovascular disease.
Coronary Heart Disease and Sleep
Hypertension, diabetes mellitus,
and obesity have all been associated
with obstructive sleep apnea and all
are risk factors for coronary heart
disease (CHD). Numerous changes
that occur as a consequence of
sleep disordered breathing are deleterious to the vascular system.
Accordingly, researchers have
investigated potential associations
between sleep apnea and CHD.
Overall, the data linking OSAS and
CHD do not appear as striking as
with OSAS and other cardiovascular diseases (e.g., hypertension,
congestive heart failure, and atrial
fibrillation). Nevertheless, there are
some provocative data linking
OSAS and CHD and the possibility
that treating OSAS may benefit
these cardiac patients. Data from
the Sleep Heart Health Study
demonstrated that severe obstructive sleep apnea increased the risk
of developing CHD in males
between the ages of 40 and 70
years; this finding was not replicated in either females or males older
than 70 years (Gottlieb et al., 2010).
Women are not exempt from this
association between OSAS and
CHD, as an older study from Sweden of more than 100 women with
CHD found that over 50% had
sleep apnea versus only 20% in
controls. A recent study found no
differences in frequency of OSAS
between females and males with
CHD (Zhao et al., 2014); but, in
this study, the females were older
and more frequently were afflicted

by kidney disease and diabetes mellitus.
In one Japanese study, the major
index of sleep apnea severity was
twice as high at the time of an acute
myocardial infarction (heart attack)
as compared to just 14 days later.
OSAS may confer a worsened
prognosis in patients with coronary
heart disease and, thus, it is of interest to determine the impact of treating OSAS. Data suggest but do not
unequivocally prove that CPAP
treatment, for example, improves
the outlook for those with both
OSAS and CHD (Marin et al.,
2005).
There is relatively little research
investigating restless legs syndrome
(RLS) and CHD. The Sleep Heart
Health Study did find that RLS
increased the likelihood for CHD.
Interestingly, there was a dose
response relationship for severity
and frequency of RLS and risk for
CHD (Winkelman et al., 2008).

study than obstructive sleep apnea.
In addition, it appears that the presence of OSAS may confer a worsened prognosis in some with systolic dysfunction (reduced ejection
fraction).
In a recent study, those who had
CHF secondary to coronary heart
disease had an increased mortality
risk associated with sleep apnea.
OSAS may lead to numerous alterations in physiology that are detrimental to the heart and, more certainly, to the diseased heart.
Increased activity of the sympathetic nervous system, increased work
requirements of the heart, repetitive
drops / returns to baseline in oxygen level, increased oxidative
stress, and increased production of
inflammatory mediators all occur
secondary to OSAS. CPAP administration has been shown to reverse
these changes and there are some
data that indicate that treating
OSAS may, over time, lead to
improvements in cardiac function,
such as better ejection fraction.

Congestive Heart Failure and Sleep
The American Heart Association
estimated in 2010 that just under
six million Americans have congestive heart failure (CHF), with most
of these being ages 65 and older.
CHF can occur both with and without reductions in ventricular ejection fraction (heart muscle pump
function). CHF has been associated
with both obstructive and central
sleep apnea (repetitive temporary
pauses in breathing during sleep
without upper airway narrowing/
occlusion). One study revealed that
roughly half of 81 patients with
CHF (systolic dysfunction type)
had sleep apnea, with central sleep
apnea being more frequent in this

Given the improvements in physiology with CPAP in heart failure
patients, it would appear that CPAP
therapy should reduce the burden of
mortality. Some data from Japan
support this contention but a recent
review of OSAS and CHF cautions
that results to date should be treated
with caution (Kasai & Bradley,
2011). It is interesting to note that
the relationship between OSAS and
CHF may be bidirectional. Return
of extra fluid from the lower
extremities during sleep can
increase neck circumference and
thereby further destabilize the
upper airway during sleep and
worsen OSAS.

Central sleep apnea and CheyneStokes breathing (a waxing and
waning breathing pattern often
associated with congestive heart
failure) have also been associated
with CHF and, further, portend
worse prognosis. Although CPAP
with or without supplementary oxygen can be utilized, a more sophisticated (and expensive) positive airway pressure device called adaptive
servo-ventilation looks to be more
effective in treating these central
sleep breathing disorders. Importantly, a multi-center and randomized study is underway to evaluate
the possible effectiveness of this
machinery in improving such
important end points as mortality
and hospitalization.
A burgeoning research literature
suggests (but does not prove) that
restless legs syndrome (RLS) and
periodic limb movements of sleep
(PLMS) may be associated with
hypertension, a risk factor for CHF.
Data from the Sleep Heart Health
Study suggest a relationship
between RLS and cardiovascular
disease, including coronary heart
disease, congestive heart failure,
and stroke (Winkelman et al.,
2008). However, this study’s
methodology could not establish a
cause and effect relationship.
Another study of RLS subjects
found that those with more PLMS
had greater risk for left ventricular
hypertrophy (thickened left ventricular wall). This is important, for left
ventricular hypertrophy appears to
increase the risk for both heart failure and mortality. Indeed, this same
study found increased rates of both
heart failure and mortality in those
with frequent PLMS; this study was
retrospective and more data are
needed to determine if RLS and
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PLMS put patients at increased risk
for negative cardiovascular outcomes and warrant more aggressive
scrutiny and treatment by clinicians.
Atrial fibrillation and Sleep
A number of different disorders of
cardiac rhythm have been associated with sleep disordered breathing.
That abnormal electrical activity of
the heart might occur is hardly surprising given some of the physiologic consequences of apnea that
we have previously mentioned.
Atrial fibrillation (an irregular heart
rhythm associated with the atrium
or top chamber of the heart) is
increasingly common and has been
noted to be even more so in older
adults. Atrial fibrillation is important, in part, because it increases the
risk of stroke and mortality. Studies
have demonstrated that OSAS and
atrial fibrillation are associated,
with one study finding almost half
of their atrial fibrillation patients
had OSAS, and another finding that
OSAS predicted an increased likelihood of atrial fibrillation after cardiac bypass for coronary heart disease (Qaddoura et al., 2014).
Treating OSAS may have salutary
effects on atrial fibrillation. Patients
with OSAS who are cardioverted
(electrically shocked) out of atrial
fibrillation are less likely to return
to that abnormal rhythm if they use
their CPAP than if they do not, with
one study finding that those who
used CPAP were about half as likely to return to atrial fibrillation at
one year compared to those who
did not use CPAP or used it “inappropriately.” Cardiologists can also
treat atrial fibrillation with catheter
ablation techniques. A meta-analy-
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sis of studies revealed that OSAS
patients with atrial fibrillation were
more likely to return to atrial fibrillation after catheter ablation; but
those who used CPAP to treat
OSAS were no more likely to
return to atrial fibrillation after
catheter ablation than those who did
not have OSAS.
The above clearly suggests that
physicians and patients alike should
be aware of the association of this
frequent arrhythmia with OSAS,
and the potential benefits of
addressing sleep apnea along with
atrial fibrillation. We have previously also mentioned central sleep
apnea and its association with congestive heart failure. A new study
reports that congestive heart failure
patients with severe central sleep
apnea were more likely to have atrial fibrillation.
There is much less information on
putative relationships between restless legs syndrome (RLS) and/ or
periodic limb movements of sleep
(PLMS) and atrial fibrillation. One
2013 study evaluated patients with
RLS and found that patients with
objectively documented frequent
PLMS had a higher likelihood of
developing more recalcitrant atrial
fibrillation.
Ventricular Arrythmias and Sleep
Limited data suggest that irregular
heart rhythms that emanate from
the lower chamber of the heart
(ventricle) can also be associated
with OSAS and/or central sleep
apnea. The Sleep Heart Health
Study data revealed that patients
with heart failure and central sleep
apnea manifested more ventricular
arrhythmias at night. Cardiologists

can use implantable cardioverter
defibrillators (ICD) to shock
patients out of potentially lethal
ventricular arrhythmias. Data
demonstrate that central and
obstructive sleep apnea patients are
more likely to require ICDs and
more likely to require “appropriate”
activation of the ICD for irregular
heart rhythms. A 2010 study from
Japan demonstrated that after ablation therapy for ventricular dysrhythmias, patients with sleep
apnea were more likely than those
without sleep apnea to have recurrent disease. A recent review from
the Journal of Clinical Sleep Medicine suggests that much more work
is needed in this important area
(Raghuram et al., 2014).
Sudden Cardiac Death and Sleep
We are, generally, most at risk for
abrupt death from heart disease in
the morning hours. OSAS confers
negative consequences such as
recurrent drops in oxygen level,
increased clotting, and surges in
blood pressure. It might follow,
then, because sleep is typically an
overnight experience, that patients
with sleep apnea would be at
greater risk for death in the middle
of the night (normally a protected
time) than patients without apnea.
This is exactly what Gami and colleagues have shown in their 2005
research paper in the New England
Journal of Medicine; examining the
potential impact of sleep apnea on
time of sudden death, they found
that patients with OSAS were twice
as likely to have sudden death
between midnight and 0600 as
those who did not carry such a
diagnosis. Further, the more severe
the sleep apnea (as defined by the
AHI, the number of partial or com-

plete pauses in breathing per hour
of sleep), the more likely one was
to pass away suddenly in the middle of the night.
Case Study #1
Mr. W., a 77-year old retired
accountant, comes to the sleep
medicine office at the request of his
primary care physician. His wife
accompanies him. Mr. W. notes that
at a recent primary care visit his
blood pressure was elevated. He
states that both his primary care
physician and his wife suspect that
he may have a sleep disorder. Mr.
W.’s wife describes her husband as
having a long history of snoring
and, more recently, she has witnessed him to have gasping respirations during sleep. Mr. W. states
that he has been more apt to nap
during the day, but ascribes his day
napping to boredom. He is currently taking medications for hypertension and hyperlipidemia. He drinks
alcohol only modestly and never
smoked.
On physical exam, he is obese, with
a body mass index of 31kg/m2. His
vital signs are normal except for a
blood pressure of 156/98. His cardiovascular exam is normal. The
sleep medicine specialist describes
the association of hypertension with
sleep apnea. A nocturnal
polysomnogram (sleep study)
reveals severe sleep apnea that
responds in large part to the application of continuous positive airway pressure (CPAP). Mr. W. initiates nasal CPAP after discussion
with both his sleep medicine specialist and primary care physician,
with positive results.

Case Study #2
Ms. D., a 74-year old widowed,
part-time nurse, presents for consultation at the request of her cardiologist. Her cardiologist is evaluating
and treating Ms. D.’s congestive
heart failure and atrial fibrillation.
The cardiologist and patient both
wonder if the patient’s atrial fibrillation could relate to an intrinsic
sleep disorder. Ms. D. notes that
she obtains about 7-8 hours of sleep
each night, but that her sleep is not
restorative and she takes a prescribed sleeping pill approximately
once a week. She obtains about 45
minutes more sleep with sleeping
pill administration but feels no
more refreshed for using it. Ms. D.
does not share the bed and cannot
report if she currently snores or has
witnessed pauses in respiration during sleep.
Physical exam reveals normal body
mass index, evidence of an irregular heart rhythm (atrial fibrillation)
and clear lungs. Records from the
cardiologist’s office confirm the
diagnosis of atrial fibrillation and
document significantly diminished
cardiac pump function with an ejection fraction of 30%. The sleep
medicine physician orders a sleep
study, which demonstrates evidence
of both obstructive and central
sleep apnea (AHI moderately elevated at 27) with only modest drops
in oxygen level. There are also mild
(20/hour) periodic limb movements
of sleep. Ms D. elects to utilize a
continuous positive airway pressure
(CPAP) machine for her sleep
apnea and to follow conservatively
her mild periodic limb movements
of sleep. After a month of treatment, she reports improved sleep
and awaits follow-up by her cardi-

ologist for input on her cardiac
status.
Conclusion
Those in sleep medicine and
throughout medicine are increasingly aware of the impact of sleep and
sleep disorders on our health. It is
important for older adults to do the
same. Insufficient sleep itself has
negative metabolic and cardiovascular effects. A gradually maturing
literature demonstrates the association of sleep disordered breathing
(both obstructive and central apnea)
and numerous cardiovascular consequences. It is also apparent that
treating sleep disordered breathing
may be cardio-protective. More
research is needed in this important
area. What is less clear is if restless
legs syndrome (RLS) and periodic
limb movements of sleep (PLMS)
are also problematic for our cardiovascular system. Given the high
prevalence of RLS/PLMS, further
research in this area would also be
instructive.
Study Questions:
1. What are the options for treating
OSAS?
2. Does treating obstructive sleep
apnea reduce blood pressure?
3. What is the most dangerous time
of day from the standpoint of our
cardiovascular system? Does it differ for those with obstructive sleep
apnea?
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